Xcout Intel
Indigo Diabetes
Indigo Diabetes N.V. is a medical device development company headquartered in Ghent, Belgium. The company focuses on creating high-tech solutions for people living with chronic diseases using proprietary nanophotonics technology.
Subscribe to see Indigo Diabetes’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Indigo Diabetes at a glance
Indigo Diabetes is a healthtech company headquartered in Belgium. Its most recent funding round, Series B, raised $44.6M in July 2020. Xcout tracks 6 named people at Indigo Diabetes, including peter j. devlin (CEO).
Indigo Diabetes leadership
- peter j. devlinCEO
- emmet lydonCOO
- Danaë DelbekeCTO and Founder
- Daniel VerstappenVP Quality and Regulatory Affairs
- Gijs KlarenbeekVP Clinical and Medical Affairs
- An HerremansMember of the Executive Committee at Ackermans & van Haaren
Indigo Diabetes funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $44.6M | 13 named | |
| Series B | $45M | 13 named | |
| Series A | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Indigo Diabetes competitors
A few of Indigo Diabetes's closest competitors — see the full list of competitors and alternatives →
DiaMonTech is an innovative medical technology company based in Berlin that develops non-invasive, pain-free glucose monitoring solutions for everyday diabetes management.
Intuity Medical, Inc. is a commercial-stage medical technology company headquartered in Fremont, California. The company specializes in developing innovative blood glucose monitoring systems and medical devices to simplify diabetes management for patients.
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
Headquartered in Fremont, California, ArKal Medical is a medical technology company that developed next-generation continuous glucose monitoring systems using proprietary MicroTip technology.
Willow Life Sciences, Inc. develops medical devices and digital health tools focused on metabolic health, chronic disease prevention, and patient monitoring. The company offers Nutu, a digital platform for weight management and diabetes prevention, alongside noninvasive optical monitoring technologies such as Rainbow Technology and Ember for clinical and personal health tracking.
Sava Technologies develops a minimally invasive biosensor platform designed for real-time continuous health monitoring beyond glucose alone, including metrics like lactate, ketones, and cortisol. The company provides affordable, multi-molecule detection technology aimed at managing chronic conditions and general wellbeing.
Get Indigo Diabetes's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Indigo Diabetes in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access